Correlation Between Invivyd and Mirum Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Invivyd and Mirum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invivyd and Mirum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invivyd and Mirum Pharmaceuticals, you can compare the effects of market volatilities on Invivyd and Mirum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invivyd with a short position of Mirum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invivyd and Mirum Pharmaceuticals.
Diversification Opportunities for Invivyd and Mirum Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Invivyd and Mirum is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and Mirum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirum Pharmaceuticals and Invivyd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invivyd are associated (or correlated) with Mirum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirum Pharmaceuticals has no effect on the direction of Invivyd i.e., Invivyd and Mirum Pharmaceuticals go up and down completely randomly.
Pair Corralation between Invivyd and Mirum Pharmaceuticals
Given the investment horizon of 90 days Invivyd is expected to generate 11.37 times more return on investment than Mirum Pharmaceuticals. However, Invivyd is 11.37 times more volatile than Mirum Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Mirum Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest 46.00 in Invivyd on December 29, 2024 and sell it today you would earn a total of 15.00 from holding Invivyd or generate 32.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Invivyd vs. Mirum Pharmaceuticals
Performance |
Timeline |
Invivyd |
Mirum Pharmaceuticals |
Invivyd and Mirum Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Invivyd and Mirum Pharmaceuticals
The main advantage of trading using opposite Invivyd and Mirum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invivyd position performs unexpectedly, Mirum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirum Pharmaceuticals will offset losses from the drop in Mirum Pharmaceuticals' long position.Invivyd vs. Recursion Pharmaceuticals | Invivyd vs. Atea Pharmaceuticals | Invivyd vs. Unity Biotechnology | Invivyd vs. Regenxbio |
Mirum Pharmaceuticals vs. Immunocore Holdings | Mirum Pharmaceuticals vs. Larimar Therapeutics | Mirum Pharmaceuticals vs. Kalvista Pharmaceuticals | Mirum Pharmaceuticals vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |